New York, United States , June 22, 2024 (GLOBE NEWSWIRE) -- The Global Fecal Calprotectin Test Market Size is to Grow from USD 126.15 Million in 2023 to USD 366.15 Million by 2033, at a CAGR of 11.24% ...
Austin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Fecal Calprotectin Testing Market Size & Trends: According to SNS Insider, the global Fecal Calprotectin Testing Market was valued at USD 4.51 billion in 2023 ...
July 22, 2010 — A new approach to the diagnosis of inflammatory bowel disease (IBD) — fecal calprotectin testing — is a useful tool for identifying patients who are most likely to need endoscopy for ...
Introduction: Fecal calprotectin (FC) is a well‑established biomarker of intestinal inflammation in Crohn disease (CD) and ulcerative colitis (UC). However, standard laboratory methods are ...
The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...
Of 575 patients enrolled in the study, 538 (94%, 248 male, 290 female) were included in the final analysis (Figure 1). Thirty-seven patients (6.4%) were excluded; 6 patients for incomplete endoscopy ...
A simple screening test identifies patients who are most likely to have inflammatory bowel disease and reduces the need for expensive, invasive and time consuming endoscopies, finds a new study. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results